secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0000950170-24-060805
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics raises ~$5.8M via 4.64M shares at $1.25/share, 25% premium to VWAP
--------------------------------------------------------------------------------

- Issued 4,640,000 common shares at $1.25 per share, a 25% premium to 30-day VWAP.
- Net proceeds of approximately $5.8 million after offering expenses.
- Transaction closed on May 14, 2024.
- Registration statement due by Aug 15, 2024; investor locked up until Nov 9, 2024.
- Investor agrees to vote shares in line with board recommendation through May 14, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024060805/0000950170-24-060805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024060805/inkt-20240513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-060805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer